Literature DB >> 8396741

Different clinicopathological types of segmental sclerosing glomerular lesions in adults.

A J Howie1, S J Lee, N J Green, K M Newbold, T Kizaki, A Koram, N T Richards, J Michael, D Adu.   

Abstract

Renal biopsies and kidneys from 111 adult patients with segmental sclerosing glomerular lesions were put into different morphological groups by pathologists unaware of clinical findings. 'Overload changes' (n = 11) were large glomeruli with hilar lesions. Ten of these patients had reduced renal mass. In the 'glomerular tip lesion' (n = 10) there were changes at the tubular origin in otherwise normal glomeruli. All patients in this group had the nephrotic syndrome, completely responsive to steroids. 'Mesangial hypercellularity with diffuse segmental changes at the glomerular tip', corresponding to 'early classical focal segmental glomerulosclerosis' (n = 18), differed from the glomerular tip lesion in that glomeruli were larger and hypercellular. Most patients with this classification had the nephrotic syndrome, several were given additional immunosuppression, and less than half had complete remission. 'Diffuse multiple segmental lesions', corresponding to 'late classical focal segmental glomerulosclerosis' (n = 16), presented usually with the nephrotic syndrome, and most of these patients had no response to immunosuppression. Unlike most other groups, in 'focal segmental sclerosing lesions' (n = 56) there were genuinely focal lesions, not in every glomerulus. Most patients had asymptomatic proteinuria. Pathological study is able to classify segmental lesions that would often be grouped as 'focal segmental glomerulosclerosis' into types with different pathogenesis, clinical findings, appropriate treatment, response to treatment, and prognosis.

Entities:  

Mesh:

Year:  1993        PMID: 8396741

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  6 in total

1.  Urinary CD80 levels as a diagnostic biomarker of minimal change disease.

Authors:  Chen Ling; Xiaorong Liu; Ying Shen; Zhi Chen; Jianfeng Fan; Yeping Jiang; Qun Meng
Journal:  Pediatr Nephrol       Date:  2014-08-21       Impact factor: 3.714

2.  Elevated macrophage migration inhibitory factor (MIF) levels in the urine of patients with focal glomerular sclerosis.

Authors:  K Matsumoto; N Maruyama; T Maruyama; Y Ohnishi; S Nonaka; A Inoshita; K Ito; S Kitajima; M Abe; A Satomura; T Fujita
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

Review 3.  Problems with 'focal segmental glomerulosclerosis'.

Authors:  Alexander J Howie
Journal:  Pediatr Nephrol       Date:  2010-12-02       Impact factor: 3.714

4.  Glomerular tip changes in childhood minimal change nephropathy.

Authors:  Alexander J Howie; Anju Agarwal; Neil J Sebire; Richard S Trompeter
Journal:  Pediatr Nephrol       Date:  2008-04-30       Impact factor: 3.714

5.  Predilection of segmental glomerulosclerosis lesions for the glomerulotubular junction area in type 1 diabetic patients: a novel mapping method.

Authors:  Behzad Najafian; Michael Mauer
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

Review 6.  Genetic studies of focal segmental glomerulosclerosis: a waste of scientific time?

Authors:  Alexander J Howie
Journal:  Pediatr Nephrol       Date:  2018-12-27       Impact factor: 3.714

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.